Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment | Taiwan News
Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment | 2022-02-28 15:00:00
Source: taiwannews.com.tw
📰 Science Driven News
Page 2 - Science Driven News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Science Driven. Real-time updates on events, politics, business and more.
Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment
Press release content from Accesswire. The AP news staff was not involved in its creation.
Source: apnews.com
Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment
Heidelberg Pharma AG / Key word(s): AllianceHeidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment27-Feb-2022 / 13:11 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.The issuer is...
Source: pharmiweb.com
AKSO and Huadong Medicine Announce Strategic Collaboration to Develop and Commercialize AB002 in Asi
- Huadong Medicine is granted from AKSO Biopharmaceutical an exclusive right to develop and commercialize AB002 in the Asia Pacific Ex-Japan region for solid tumors; AKSO Biopharmaceutical to receive up to 75 million USD upfront, R&D funding, potential regulatory and commercial milestone payments- Strategic partners...
Dongzhouj Liu Rebecca Miao Amato Giaccia Biopharmaceutical Inc Dragon Financial Partners Ltd Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd
Source: pharmiweb.com
AKSO Biopharmaceutical, Inc.: AKSO and Huadong Medicine Announce Strategic Collaboration to Develop and Commercialize AB002 in Asia Pacific Ex-Japan
Huadong Medicine is granted from AKSO Biopharmaceutical an exclusive right to develop and commercialize AB002 in the Asia Pacific Ex-Japan region for solid tumors; AKSO Biopharmaceutical to receive up
Dongzhouj Liu Kostenloser Wertpapierhandel Rebecca Miao Amato Giaccia Biopharmaceutical Inc Dragon Financial Partners Ltd
Source: finanznachrichten.de
Provention Bio and Huadong Announce Strategic Collaboration to Develop and Commercialize PRV-3279 in Greater China
/PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, and...
Source: prnewswire.com